Pfizer and BioNTech to deliver 500 million Covid-19 vaccine doses to the US
The US Government will donate the vaccine doses to low and lower-middle-income countries.
Supply Chain
Regenerative medicine: ready for the big leagues?
What is at the cutting-edge of regenerative medicine in 2021, and are these complex products...
Drug dispensing goes digital
Pharmacists are looking to drive efficiencies in medication management and drug dispensing by leveraging robotic...
Vaxxinity CEO Mei Mei Hu on vaccine research and democratising health
Vaxxinity CEO Mei Mei Hu discusses her newly-formed company, its vaccine programmes and her mission...
Covid-19 vaccine inequity: the debate over patent waivers intensifies
Severe vaccine shortages in poorer countries have brought the issue of intellectual property rights to...
Pharma supply chain will benefit most from adopting blockchain: Poll
Blockchain technology can play a crucial role in bringing a paradigm shift in the operational structure of the pharmaceutical industry by improving its efficiency, security, and management.
Covishield: India’s vaccine giant struggles to deliver as local cases surge
In January, the Serum Institute of India pledged to provide doses of AstraZeneca’s Covid-19 jab to some of the world’s poorest countries. Now, with infections surging in India and supplies of critical items dwindling, the...
EMA review concludes AstraZeneca Covid-19 vaccine is “safe and effective”
The European Medicines Agency (EMA) has concluded that the AstraZeneca/Oxford University Covid-19 vaccine is “safe and effective” after an investigation into a potential link between the vaccine and blood clots in a small number of...
AstraZeneca to supply 500,000 doses of Covid-19 antibody to the US
AstraZeneca (AZ) has signed an agreement with the US Department of Health and Human Services (HHS) and the Department of Defense (DoD) for the supply of up to 500,000 additional doses of its Covid-19 antibody...
Delaying Covid-19 vaccine booster rooted in some clinical data versus reducing doses, but neither approach likely to solve distribution quandaries
Among the strategies being proposed to extend available Covid-19 vaccine supplies, delaying the second dose of an authorised two-dose vaccine is relatively more grounded in clinical data than reducing doses, investigators said.
Cross-EU drug supply chain to be most affected post Brexit: Poll
The UK’s decision to opt out of the European Union (EU) has set numerous industries up for disruptions especially after the official exit in January 2020.
